(Q79695107)

English

Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US

scientific article published on 01 March 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17265519%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17265519%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

United States of America

1 reference

based on heuristic

inferred from title

Jeremy Chancellor

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17265519%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Milton Weinstein

5

object named as

Milton C Weinstein

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17265519%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Samuel Aballéa

1

object named as

Samuel Aballéa

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17265519%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Maria Raikou

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17265519%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Michael F Drummond

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17265519%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Sophia Jourdan

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17265519%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

John Bridgewater

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17265519%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 March 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17265519%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17265519%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

109

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17265519%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17265519%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1082-1089

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17265519%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22512

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant therapy for stage III colon cancer: economics returns to research and cost-effectiveness of treatment.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22512

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant chemotherapy (5-fluorouracil and levamisole) in Dukes' B and C colorectal carcinoma. A cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22512

7 January 2021

based on heuristic

inferred from DOI database lookup

Parametric extrapolation of survival estimates with applications to quality of life evaluation of treatments. International Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22512

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22512

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life in survivors of colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22512

7 January 2021

based on heuristic

inferred from DOI database lookup

A national catalog of preference-based scores for chronic conditions in the United States

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22512

7 January 2021

based on heuristic

inferred from DOI database lookup

US valuation of the EQ-5D health states: development and testing of the D1 valuation model.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22512

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimating medical costs from incomplete follow-up data

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22512

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22512

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer prevention: strong science and real medicine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22512

7 January 2021

based on heuristic

inferred from DOI database lookup

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22512

7 January 2021

based on heuristic

inferred from DOI database lookup

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22512

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22512

7 January 2021

based on heuristic

inferred from DOI database lookup

The price tag on progress--chemotherapy for colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22512

7 January 2021

based on heuristic

inferred from DOI database lookup

Willingness to pay for a quality-adjusted life year: in search of a standard

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22512

7 January 2021

based on heuristic

inferred from DOI database lookup

What is the price of life and why doesn't it increase at the rate of inflation?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22512

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22512

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of colorectal cancer in elderly patients: focus on the cost of chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22512

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost effectiveness of adjuvant intraportal chemotherapy in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22512

7 January 2021

based on heuristic

inferred from DOI database lookup

A cost-utility analysis of second-line chemotherapy in metastatic breast cancer. Docetaxel versus paclitaxel versus vinorelbine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22512

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensity of chemotherapy-induced emesis and overall survival as determinants of a global utility score.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22512

7 January 2021

based on heuristic

inferred from DOI database lookup

A cost utility analysis of treatment options for gallstone disease: methodological issues and results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22512

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.22512

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17265519%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17265519%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79695107&oldid=1949010147"